An in silico analysis of the impact of POLE mutations on cladribine docking.
Loganathan L, Al-Haidose A, Ganesh Kumar A, Sujatha LB, Carlus FH, Alharbi A, Alhyassat S, Muthusamy K, Carlus SJ, Abdallah AM.
Loganathan L, et al. Among authors: muthusamy k.
Eur Rev Med Pharmacol Sci. 2022 Oct;26(20):7580-7593. doi: 10.26355/eurrev_202210_30033.
Eur Rev Med Pharmacol Sci. 2022.
PMID: 36314330
Free article.